Lind, Margaret L. http://orcid.org/0000-0002-1572-4074
Dorion, Murilo
Houde, Amy J.
Lansing, Mary
Lapidus, Sarah
Thomas, Russell
Yildirim, Inci http://orcid.org/0000-0002-8631-0020
Omer, Saad B.
Schulz, Wade L. http://orcid.org/0000-0002-2048-4028
Andrews, Jason R. http://orcid.org/0000-0002-5967-251X
Hitchings, Matt D. T. http://orcid.org/0000-0003-2327-3557
Kennedy, Byron S.
Richeson, Robert P.
Cummings, Derek A. T. http://orcid.org/0000-0002-9437-1907
Ko, Albert I. http://orcid.org/0000-0001-9023-2339
Funding for this research was provided by:
State of Connecticut Department of Public Health
Article History
Received: 4 March 2023
Accepted: 7 August 2023
First Online: 19 August 2023
Competing interests
: A.I.K. is as an expert panel member for Reckitt Global Hygiene Institute, and a consultant for Tata Medical and Diagnostics and Regeneron Pharmaceuticals and has received grants related to COVID-19 research outside the scope of the proposed work from Regeneron Pharmaceuticals and Tata Medical and Diagnostics. W.L.S. was an investigator for a research agreement, through Yale University, from the Shenzhen Center for Health Information for work to advance intelligent disease prevention and health promotion; collaborates with the National Center for Cardiovascular Diseases in Beijing; is a technical consultant to Hugo Health, a personal health information platform, and co-founder of Refactor Health, an AI-augmented data management platform for healthcare; and has received grants related to COVID-19 research outside the scope of the proposed work from Regeneron Pharmaceutical. The other authors declare no competing interests.